is mounjaro a tirzepatide (Tirzepatide) Side Effects: What To Know Mounjaro will remain off shortage

Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP and GLP-1 receptor agonist that has transformed metabolic disease treatment

Heres a quick look at the most common side effects for each medication, as reported by at least 5% of people in clinical trials: For some people, these side effects can become disruptive, leading them to seek an alternative medication

Originally presented at the American Diabetes Association (ADA) 82nd Scientific Sessions in 2022, the phase 3 SURMOUNT-1 trial was designed as a double-blind, randomized, controlled trial to assess the effects of 5 mg, 10 mg, or 15 mg of tirzepatide once weekly relative to placebo for weight loss

The side effects of Wegovy, particularly gastrointestinal symptoms like nausea and vomiting, typically diminish over time as the body adjusts to the medication

Medical weight loss provides a safe, effective way to manage chronic weight issues and health concerns